{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:10:46Z","timestamp":1740107446634,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00280-023-04638-0","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T09:02:44Z","timestamp":1706778164000},"page":"481-496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations"],"prefix":"10.1007","volume":"93","author":[{"given":"Xiaoya","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xufeng","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-6855","authenticated-orcid":false,"given":"Tianbo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"issue":"5","key":"4638_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.medcli.2019.08.007","volume":"154","author":"E Montan\u00e9","year":"2020","unstructured":"Montan\u00e9 E, Santesmases J (2020) Adverse drug reactions. Med Clin (Barc) 154(5):178\u2013184. https:\/\/doi.org\/10.1016\/j.medcli.2019.08.007","journal-title":"Med Clin (Barc)"},{"key":"4638_CR2","doi-asserted-by":"publisher","first-page":"692234","DOI":"10.3389\/fgene.2021.692234","volume":"12","author":"IM Langmia","year":"2021","unstructured":"Langmia IM, Just KS, Yamoune S et al (2021) CYP2B6 functional variability in drug metabolism and exposure across populations-implication for drug safety, dosing, and individualized therapy. Front Genet 12:692234. https:\/\/doi.org\/10.3389\/fgene.2021.692234","journal-title":"Front Genet"},{"issue":"6","key":"4638_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","volume":"24","author":"M Pirmohamed","year":"2023","unstructured":"Pirmohamed M (2023) Pharmacogenomics: current status and future perspectives. Nat Rev Genet 24(6):350\u2013362. https:\/\/doi.org\/10.1038\/s41576-022-00572-8","journal-title":"Nat Rev Genet"},{"issue":"2","key":"4638_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cpt.1491","volume":"106","author":"H Zhang","year":"2019","unstructured":"Zhang H, De T, Zhong Y et al (2019) The advantages and challenges of diversity in pharmacogenomics: can minority populations bring us closer to implementation? Clin Pharmacol Ther 106(2):338\u2013349. https:\/\/doi.org\/10.1002\/cpt.1491","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"4638_CR5","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/cpt.1323","volume":"105","author":"E Danese","year":"2019","unstructured":"Danese E, Raimondi S, Montagnana M et al (2019) Effect of CYP4F2, VKORC1, and CYP2C9 in influencing coumarin dose: a single-patient data meta-analysis in more than 15,000 individuals. Clin Pharmacol Ther 105(6):1477\u20131491. https:\/\/doi.org\/10.1002\/cpt.1323","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"4638_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt.668","volume":"102","author":"JA Johnson","year":"2017","unstructured":"Johnson JA, Caudle KE, Gong L et al (2017) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update. Clin Pharmacol Ther 102(3):397\u2013404. https:\/\/doi.org\/10.1002\/cpt.668","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"4638_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cpt.2816","volume":"113","author":"BR Sitabule","year":"2023","unstructured":"Sitabule BR, Othman H, Choudhury A et al (2023) Promoting pharmacogenomics in Africa: perspectives from variation in G6PD and other pharmacogenes. Clin Pharmacol Ther 113(3):476\u2013479. https:\/\/doi.org\/10.1002\/cpt.2816","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"4638_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/infdis\/jiac024","volume":"226","author":"DW Haas","year":"2022","unstructured":"Haas DW, Abdelwahab MT, van Beek SW et al (2022) Pharmacogenetics of between-individual variability in plasma clearance of bedaquiline and clofazimine in South Africa. J Infect Dis 226(1):147\u2013156. https:\/\/doi.org\/10.1093\/infdis\/jiac024","journal-title":"J Infect Dis"},{"issue":"1","key":"4638_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12863-021-00999-8","volume":"22","author":"D Li","year":"2021","unstructured":"Li D, Peng L, Xing S et al (2021) Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China. BMC Genom Data. 22(1):51. https:\/\/doi.org\/10.1186\/s12863-021-00999-8","journal-title":"BMC Genom Data."},{"issue":"7","key":"4638_CR10","doi-asserted-by":"publisher","first-page":"e1231","DOI":"10.1002\/mgg3.1231","volume":"8","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Dai R, Chen W et al (2020) Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province. Mol Genet Genomic Med 8(7):e1231. https:\/\/doi.org\/10.1002\/mgg3.1231","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"4638_CR11","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1002\/mgg3.574","volume":"7","author":"C Zhang","year":"2019","unstructured":"Zhang C, Guo W, Cheng Y et al (2019) Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China. Mol Genet Genomic Med 7(5):e574. https:\/\/doi.org\/10.1002\/mgg3.574","journal-title":"Mol Genet Genomic Med"},{"issue":"9","key":"4638_CR12","doi-asserted-by":"publisher","first-page":"e884","DOI":"10.1002\/mgg3.884","volume":"7","author":"W Chen","year":"2019","unstructured":"Chen W, Ding H, Cheng Y et al (2019) Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China. Mol Genet Genomic Med 7(9):e884. https:\/\/doi.org\/10.1002\/mgg3.884","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"4638_CR13","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.21037\/apm-20-1075","volume":"9","author":"W Dong","year":"2020","unstructured":"Dong W, Wang D, Li Y et al (2020) Genetic polymorphism of HPA1\u201317 alloantigen system in the Achang and Jingpo populations population in Yunnan. Ann Palliat Med. 9(4):1990\u20131996. https:\/\/doi.org\/10.21037\/apm-20-1075","journal-title":"Ann Palliat Med."},{"key":"4638_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H (2021) Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 18:17. https:\/\/doi.org\/10.3352\/jeehp.2021.18.17","journal-title":"J Educ Eval Health Prof."},{"key":"4638_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043383","author":"CR Chamboko","year":"2023","unstructured":"Chamboko CR, Veldman W, Tata RB et al (2023) Human Cytochrome P450 1, 2, 3 families as pharmacogenes with emphases on their antimalarial and antituberculosis drugs and prevalent African alleles. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24043383","journal-title":"Int J Mol Sci"},{"issue":"29","key":"4638_CR16","doi-asserted-by":"publisher","first-page":"11001","DOI":"10.1021\/acs.jafc.3c01750","volume":"71","author":"J Zhao","year":"2023","unstructured":"Zhao J, Lin L, Hadiatullah H et al (2023) Characterization of six diamide insecticides on ryanodine receptor: resistance and species selectivity. J Agric Food Chem 71(29):11001\u201311007. https:\/\/doi.org\/10.1021\/acs.jafc.3c01750","journal-title":"J Agric Food Chem"},{"key":"4638_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biology12091156","author":"O Mart\u00ednez-Iglesias","year":"2023","unstructured":"Mart\u00ednez-Iglesias O, Naidoo V, Carrera I et al (2023) Influence of metabolic, transporter, and pathogenic genes on pharmacogenetics and DNA methylation in neurological disorders. Biology (Basel). https:\/\/doi.org\/10.3390\/biology12091156","journal-title":"Biology (Basel)"},{"key":"4638_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ph16111596","author":"N Principi","year":"2023","unstructured":"Principi N, Petropulacos K, Esposito S (2023) Impact of pharmacogenomics in clinical practice. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph16111596","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"4638_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/cts.12869","volume":"14","author":"M Arbitrio","year":"2021","unstructured":"Arbitrio M, Scionti F, Di Martino MT et al (2021) Pharmacogenomics biomarker discovery and validation for translation in clinical practice. Clin Transl Sci 14(1):113\u2013119. https:\/\/doi.org\/10.1111\/cts.12869","journal-title":"Clin Transl Sci"},{"issue":"11","key":"4638_CR20","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/j.1365-2222.2008.03082.x","volume":"38","author":"TH Kim","year":"2008","unstructured":"Kim TH, Chang HS, Park SM et al (2008) Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy 38(11):1727\u20131737. https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03082.x","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"4638_CR21","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1097\/HJH.0b013e32833c7a4d","volume":"28","author":"MR Irvin","year":"2010","unstructured":"Irvin MR, Lynch AI, Kabagambe EK et al (2010) Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study. J Hypertens 28(10):2076\u20132083. https:\/\/doi.org\/10.1097\/HJH.0b013e32833c7a4d","journal-title":"J Hypertens"},{"issue":"2","key":"4638_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.25100\/cm.v47i2.2188","volume":"47","author":"F Ferreira de Oliveira","year":"2016","unstructured":"Ferreira de Oliveira F, Berretta JM, Suchi Chen E et al (2016) Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease. Colomb Med (CA). 47(2):76\u201380","journal-title":"Colomb Med (CA)."},{"issue":"8","key":"4638_CR23","doi-asserted-by":"publisher","first-page":"e105254","DOI":"10.1371\/journal.pone.0105254","volume":"9","author":"LK Vogel","year":"2014","unstructured":"Vogel LK, S\u00e6b\u00f8 M, H\u00f8yer H et al (2014) Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis. PLoS ONE 9(8):e105254. https:\/\/doi.org\/10.1371\/journal.pone.0105254","journal-title":"PLoS ONE"},{"key":"4638_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12973","author":"J Yang","year":"2018","unstructured":"Yang J, Chen X, Zhou J et al (2018) Associations of candidate gene polymorphisms with poor responsiveness to aspirin: a meta-analysis. Clin Exp Pharmacol Physiol. https:\/\/doi.org\/10.1111\/1440-1681.12973","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"4638_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11239-012-0777-8","volume":"35","author":"V Sharma","year":"2013","unstructured":"Sharma V, Kaul S, Al-Hazzani A et al (2013) Association of COX-2 rs20417 with aspirin resistance. J Thromb Thrombolysis 35(1):95\u201399. https:\/\/doi.org\/10.1007\/s11239-012-0777-8","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"4638_CR26","doi-asserted-by":"publisher","first-page":"e71126","DOI":"10.1371\/journal.pone.0071126","volume":"8","author":"M Nagao","year":"2013","unstructured":"Nagao M, Sato Y, Yamauchi A (2013) A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer. PLoS ONE 8(8):e71126. https:\/\/doi.org\/10.1371\/journal.pone.0071126","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"4638_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12863-020-00909-4","volume":"21","author":"RP Tiis","year":"2020","unstructured":"Tiis RP, Osipova LP, Lichman DV et al (2020) Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia. BMC Genet 21(Suppl 1):115. https:\/\/doi.org\/10.1186\/s12863-020-00909-4","journal-title":"BMC Genet"},{"issue":"3","key":"4638_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/03602530802186603","volume":"40","author":"E Sim","year":"2008","unstructured":"Sim E, Walters K, Boukouvala S (2008) Arylamine N-acetyltransferases: from structure to function. Drug Metab Rev 40(3):479\u2013510. https:\/\/doi.org\/10.1080\/03602530802186603","journal-title":"Drug Metab Rev"},{"issue":"9","key":"4638_CR29","doi-asserted-by":"publisher","first-page":"e44629","DOI":"10.1371\/journal.pone.0044629","volume":"7","author":"JD Ruiz","year":"2012","unstructured":"Ruiz JD, Mart\u00ednez C, Anderson K et al (2012) The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotype. PLoS ONE 7(9):e44629. https:\/\/doi.org\/10.1371\/journal.pone.0044629","journal-title":"PLoS ONE"},{"issue":"5","key":"4638_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.4103\/0971-5916.187106","volume":"143","author":"PS Adole","year":"2016","unstructured":"Adole PS, Kharbanda PS, Sharma S (2016) N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures\u2014a pilot study. Indian J Med Res 143(5):581\u2013590. https:\/\/doi.org\/10.4103\/0971-5916.187106","journal-title":"Indian J Med Res"},{"issue":"8","key":"4638_CR31","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/jgh.12194","volume":"28","author":"VH Gupta","year":"2013","unstructured":"Gupta VH, Amarapurkar DN, Singh M et al (2013) Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India. J Gastroenterol Hepatol 28(8):1368\u20131374. https:\/\/doi.org\/10.1111\/jgh.12194","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4638_CR32","doi-asserted-by":"publisher","first-page":"e85905","DOI":"10.1371\/journal.pone.0085905","volume":"9","author":"Y Xiang","year":"2014","unstructured":"Xiang Y, Ma L, Wu W et al (2014) The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1. PLoS ONE 9(1):e85905. https:\/\/doi.org\/10.1371\/journal.pone.0085905","journal-title":"PLoS ONE"},{"issue":"1","key":"4638_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00432-022-04332-3","volume":"149","author":"ZK Lawi","year":"2023","unstructured":"Lawi ZK, Al-Shuhaib MBS, Amara IB (2023) The rs1801280 SNP is associated with non-small cell lung carcinoma by exhibiting a highly deleterious effect on N-acetyltransferase 2. J Cancer Res Clin Oncol 149(1):147\u2013157. https:\/\/doi.org\/10.1007\/s00432-022-04332-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"4638_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1164\/rccm.200509-1412OC","volume":"173","author":"JJ Lima","year":"2006","unstructured":"Lima JJ, Zhang S, Grant A et al (2006) Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173(4):379\u2013385. https:\/\/doi.org\/10.1164\/rccm.200509-1412OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4638_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/FPC.0b013e328326e0b1","volume":"19","author":"KG Tantisira","year":"2009","unstructured":"Tantisira KG, Lima J, Sylvia J et al (2009) 5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci. Pharmacogenet Genomics 19(3):244\u2013247. https:\/\/doi.org\/10.1097\/FPC.0b013e328326e0b1","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"4638_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2710.2011.01248.x","volume":"37","author":"H Kotani","year":"2012","unstructured":"Kotani H, Kishi R, Mouri A et al (2012) Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma. J Clin Pharm Ther 37(1):112\u2013116. https:\/\/doi.org\/10.1111\/j.1365-2710.2011.01248.x","journal-title":"J Clin Pharm Ther"},{"key":"4638_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/genes11111295","author":"C Taylor","year":"2020","unstructured":"Taylor C, Crosby I, Yip V et al (2020) A review of the important role of CYP2D6 in pharmacogenomics. Genes (Basel). https:\/\/doi.org\/10.3390\/genes11111295","journal-title":"Genes (Basel)"},{"issue":"6","key":"4638_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/15563650.2015.1049355","volume":"53","author":"V Haufroid","year":"2015","unstructured":"Haufroid V, Hantson P (2015) CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants. Clin Toxicol (Phila) 53(6):501\u2013510. https:\/\/doi.org\/10.3109\/15563650.2015.1049355","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"4638_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bcp.12348","volume":"78","author":"Y Ji","year":"2014","unstructured":"Ji Y, Schaid DJ, Desta Z et al (2014) Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations. Br J Clin Pharmacol 78(2):373\u2013383. https:\/\/doi.org\/10.1111\/bcp.12348","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"4638_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00404-018-4791-8","volume":"298","author":"CJ Sun","year":"2018","unstructured":"Sun CJ, Li L, Li XY et al (2018) Associations of polymorphisms of CYP2D6 and CYP2C9 with early onset severe pre-eclampsia and response to labetalol therapy. Arch Gynecol Obstet 298(1):125\u2013132. https:\/\/doi.org\/10.1007\/s00404-018-4791-8","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"4638_CR41","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.clinthera.2018.02.002","volume":"40","author":"C Peng","year":"2018","unstructured":"Peng C, Ding Y, Yi X et al (2018) Polymorphisms in CYP450 genes and the therapeutic effect of atorvastatin on ischemic stroke: a retrospective cohort study in chinese population. Clin Ther 40(3):469-477.e462. https:\/\/doi.org\/10.1016\/j.clinthera.2018.02.002","journal-title":"Clin Ther"},{"key":"4638_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/pgpm.S32160","volume":"5","author":"E Sirachainan","year":"2012","unstructured":"Sirachainan E, Jaruhathai S, Trachu N et al (2012) CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients. Pharmgenom Pers Med 5:149\u2013153. https:\/\/doi.org\/10.2147\/pgpm.S32160","journal-title":"Pharmgenom Pers Med"},{"key":"4638_CR43","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.2147\/ott.S149197","volume":"10","author":"J Lu","year":"2017","unstructured":"Lu J, Li H, Guo P et al (2017) The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis. Onco Targets Ther 10:5429\u20135437. https:\/\/doi.org\/10.2147\/ott.S149197","journal-title":"Onco Targets Ther"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-023-04638-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-023-04638-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-023-04638-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T17:02:52Z","timestamp":1713978172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-023-04638-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["4638"],"URL":"https:\/\/doi.org\/10.1007\/s00280-023-04638-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the study protocol approved by Northwest University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}